Laboratory Screen for IBS
For patients presenting with IBS symptoms, perform celiac serology (IgA tissue transglutaminase with total IgA) and stool testing for Giardia as the two strongest evidence-based tests, then add fecal calprotectin or fecal lactoferrin to screen for inflammatory bowel disease. 1
Core Recommended Tests (Strong Evidence)
Essential Tests for All Patients
Celiac disease screening: IgA tissue transglutaminase (IgA-tTG) PLUS total IgA level to detect IgA deficiency (strong recommendation, moderate quality evidence) 1, 2, 3, 4
Stool testing for Giardia (strong recommendation, high quality evidence) 1, 2
- Giardia is the most common parasitic cause of chronic diarrhea that presents as IBS 2
Inflammatory Bowel Disease Screening
- Fecal calprotectin OR fecal lactoferrin (conditional recommendation, low quality evidence) 1, 2, 3, 4
Additional Tests Based on Clinical Context
Complete Blood Count
- CBC to screen for anemia and inflammatory processes 2, 3, 5
- Anemia is an alarm feature requiring more extensive workup 3
Tests to Consider (Conditional Recommendations)
Bile acid diarrhea testing in patients with IBS-D who don't respond to initial therapy (conditional recommendation, low quality evidence) 1
Lactose breath testing for patients consuming >0.5 pint (280 ml) of milk daily, especially those from high-risk ethnic groups 1, 2, 3
- Patient-reported lactose intolerance correlates poorly with objective evidence 1
Tests NOT Recommended
Avoid These Blood Tests for IBD Screening
- Do NOT use ESR or CRP alone to screen for IBD (conditional recommendation against, low quality evidence) 1, 2
Other Tests to Avoid
Do NOT test for ova and parasites (other than Giardia) unless travel history to or recent immigration from high-risk areas 1, 2
Do NOT use serologic tests for IBS diagnosis (no recommendation due to knowledge gap) 1
- Tests for anti-cytolethal distending toxin B and anti-vinculin antibodies have low sensitivity (20-40%) despite high specificity 1
Do NOT perform ultrasound as it detects incidental asymptomatic findings (gallstones, fibroids) in 8% of patients, leading to inappropriate surgery 1, 2
Age-Specific Considerations
Patients Under 45 Years
- Young patients with typical IBS symptoms and no alarm features can be diagnosed with the minimal testing panel above 2
- No colonoscopy needed if no alarm features present 2
Patients Over 50 Years or High-Risk Features
- Colonoscopy indicated for patients ≥50 years at symptom onset OR positive family history of colorectal cancer, regardless of symptom pattern 2, 3
- Stool occult blood testing recommended 2, 3
Critical Alarm Features Requiring Extensive Workup
If ANY of these are present, perform comprehensive evaluation beyond the basic IBS screen: 3
- Unintentional weight loss
- Rectal bleeding or positive fecal occult blood
- Fever
- Anemia on CBC
- Elevated fecal calprotectin
- Nocturnal diarrhea
- Age >50 years at symptom onset
- Family history of IBD or colorectal cancer
- Acute onset in previously well patient
Common Pitfalls to Avoid
- Don't rely on patient-reported food intolerances without objective testing—this leads to unnecessary dietary restrictions 2
- Don't skip celiac testing even if symptoms seem typical for IBS—celiac disease is common and treatable 1, 2
- Don't order colonoscopy reflexively in young patients without alarm features—it's not cost-effective 2
- Don't assume normal CRP/ESR rules out IBD—use fecal calprotectin instead 1, 2